 Momenta Pharmaceuticals, Inc. NASDAQ:MNTA Investment analysts at Piper Sandler lowered their FY2022 earnings per share EPS estimates for shares of Momenta Pharmaceuticals in a research report issued to clients and investors on Wednesday, July 29th. Piper Sandler analyst T. Van. Buren now anticipates that the biotechnology company will post earnings per share of 1.65 ... 